Treatment of Non-Anastomotic Biliary Strictures after Liver Transplantation: How Effective Is Our Current Treatment Strategy?

ABSTRACT:

Background

Non-anastomotic biliary strictures (NAS) are a common cause of morbidity and mortality after liver transplantation.

Methods

All patients with NAS from 2008 to 2016 were retrospectively analyzed. The success rate and overall mortality of an ERCP-based stent program (EBSP) were the primary outcomes.

Results

A total of 40 (13.9%) patients with NAS were identified, of which 35 patients were further treated in an EBSP. Furthermore, 16 (46%) patients terminated EBSP successfully, and nine (26%) patients died during the program. All deaths were caused by cholangitis. Of those, one (11%) patient had an extrahepatic stricture, while the other eight patients had either intrahepatic (3, 33%) or combined extra- and intrahepatic strictures (5, 56%). Risk factors of over

SUBMITTER: Michael FA 

PROVIDER: S-EPMC10219240 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature